切换至 "中华医学电子期刊资源库"

中华普外科手术学杂志(电子版) ›› 2024, Vol. 18 ›› Issue (04) : 448 -451. doi: 10.3877/cma.j.issn.1674-3946.2024.04.026

综述

核梭杆菌和胰腺癌的关系及临床意义
朱江1, 张进1,(), 孔云飞1, 李军1, 宋旭1   
  1. 1. 212002 江苏镇江,江苏大学附属医院肝胆外科
  • 收稿日期:2023-09-15 出版日期:2024-08-26
  • 通信作者: 张进

The relationship between Fusobacterium nucleatum and pancreatic cancer and its clinical significance

Jiang Zhu1, Jin Zhang1,(), YunFei Kong1, Jun Li1, Xu Song1   

  1. 1. Department of Hepatobiliary Surgery, Affiliated Hospital of Jiangsu University, Zhenjiang Jiangsu Province 212002, China
  • Received:2023-09-15 Published:2024-08-26
  • Corresponding author: Jin Zhang
  • Supported by:
    National Natural Science Foundation of China(81303693)
引用本文:

朱江, 张进, 孔云飞, 李军, 宋旭. 核梭杆菌和胰腺癌的关系及临床意义[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(04): 448-451.

Jiang Zhu, Jin Zhang, YunFei Kong, Jun Li, Xu Song. The relationship between Fusobacterium nucleatum and pancreatic cancer and its clinical significance[J/OL]. Chinese Journal of Operative Procedures of General Surgery(Electronic Edition), 2024, 18(04): 448-451.

核梭杆菌常常定植在人体的自然腔道中,尤其富集在口腔,可以与宿主产生共生关系。随着近些年对核梭杆菌的深入研究,发现核梭杆菌和多种疾病相关。最近的研究发现其感染和胰腺癌的发生、发展息息相关。研究表明,核梭杆菌在胰腺肿瘤组织中丰度更高,并且核梭杆菌和胰腺癌患者预后差息息相关,同时核梭杆菌能够通过多种机制促进胰腺癌的发生发展。本文对核梭杆菌和胰腺癌的关系及其对胰腺癌的发生发展机制进行综述,能够为我国在胰腺癌诊断或治疗上提供一定的参考价值。

Fusobacterium nucleatum often colonizes in the natural cavity of the human body, especially in the mouth, and can have a symbiotic relationship with the host. With the in-depth study of Clostridium nucleatum in recent years, it has been found that Clostridium nucleatum is related to many diseases. Recent studies have found that its infection is closely related to the occurrence and development of pancreatic cancer. Studies have shown that Clostridium nucleatum is more abundant in pancreatic tumor tissues, and Clostridium nucleatum is closely related to poor prognosis of pancreatic cancer patients, and Clostridium nucleatum can promote the occurrence and development of pancreatic cancer through multiple mechanisms. In this paper, the relationship between Fusobacterium nucleum and pancreatic cancer and its occurrence and development mechanism were reviewed, which could provide some reference value in the diagnosis or treatment of pancreatic cancer in our country.

[1]
张太平,申鹏,赵玉沛. 不断提高胰腺癌诊治规范化水平[J/CD]. 中华普外科手术学杂志(电子版)2015, 9(04): 231-234.
[2]
国家卫生健康委办公厅. 胰腺癌诊疗指南(2022年版)[J]. 临床肝胆病杂志,2022, 38(05): 1006-1030.
[3]
Alon-Maimon TMandelboim OBachrach G.Fusobacterium nucleatum and cancer[J]. Periodontol 2000, 2022, 89(1): 166-180.
[4]
Quaglio AEVGrillo TGDe Oliveira ECS,et al. Gut microbiota,inflammatory bowel disease and colorectal cancer[J]. World J Gastroenterol2022, 28(30): 4053-4060.
[5]
Kunovsky LDite PJabandziev P,et al. Helicobacter pylori infection and other bacteria in pancreatic cancer and autoimmune pancreatitis[J]. World J Gastrointest Oncol2021, 13(8): 835-844.
[6]
Bellotti RSpeth CAdolph TE,et al. Micro- and Mycobiota Dysbiosis in Pancreatic Ductal Adenocarcinoma Development[J]. Cancers(Basel)2021, 13(14): 3431.
[7]
赖冰,刘璐,谢建军,等. 具核梭杆菌与结直肠癌的关系及其临床意义[J]. 现代肿瘤医学2022, 30(15): 2860-2863.
[8]
Meng QGao QMehrazarin S,et al. Fusobacterium nucleatum secretes amyloid-like FadA to enhance pathogenicity[J]. EMBO Rep2021, 22(7): e52891.
[9]
Lopez LRBleich RMArthur JC. Microbiota Effects on Carcinogenesis: Initiation,Promotion,and Progression[J]. Annu Rev Med2021, 72:243-261.
[10]
Mitsuhashi KNosho KSukawa Y,et al. Association of Fusobacterium species in pancreatic cancer tissues with molecular features and prognosis[J]. Oncotarget2015, 6(9): 7209-7220.
[11]
Kohi SMacgregor-das ADbouk M,et al. Alterations in the Duodenal Fluid Microbiome of Patients With Pancreatic Cancer[J]. Clin Gastroenterol Hepatol2022, 20(2): e196-e227.
[12]
Chung MZhao NMeier R,et al. Comparisons of oral,intestinal,and pancreatic bacterial microbiomes in patients with pancreatic cancer and other gastrointestinal diseases[J]. J Oral Microbiol2021, 13(1): 1887680.
[13]
Del Castillo EMeier RChung M,et al. The Microbiomes of Pancreatic and Duodenum Tissue Overlap and Are Highly Subject Specific but Differ between Pancreatic Cancer and Noncancer Subjects[J]. Cancer Epidemiol Biomarkers Prev2019, 28(2): 370-383.
[14]
Nejman DLivyatan IFuks G,et al. The human tumor microbiome is composed of tumor type-specific intracellular bacteria[J]. Science2020, 368(6494): 973-980.
[15]
Guo PTian ZKong X,et al. FadA promotes DNA damage and progression of Fusobacterium nucleatum-induced colorectal cancer through up-regulation of chk2[J]. J Exp Clin Cancer Res2020, 39(1): 202.
[16]
Parhi LAbed JShhadeh A,et al. Placental colonization by Fusobacterium nucleatum is mediated by binding of the Fap2 lectin to placentally displayed Gal-GalNAc[J]. Cell Rep2022, 38(12): 110537.
[17]
Casasanta MAYoo CCUdayasuryan B,et al. Fusobacterium nucleatum host-cell binding and invasion induces IL-8 and CXCL1 secretion that drives colorectal cancer cell migration[J]. Sci Signal2020, 13(641): eaba9157.
[18]
Parhi LAlon-Maimon TSol A,et al. Breast cancer colonization by Fusobacterium nucleatum accelerates tumor growth and metastatic progression[J]. Nat Commun2020, 11(1): 3259.
[19]
毛旭虎,童亚楠. 具核梭杆菌研究进展[J]. 第三军医大学学报2019, 41(19): 1867-1872.
[20]
Kurtzman GMHorowitz RAJohnson R,et al. The systemic oral health connection: Biofilms[J]. Medicine(Baltimore)2022, 101(46): e30517.
[21]
Wu JLi QFu X. Fusobacterium nucleatum Contributes to the Carcinogenesis of Colorectal Cancer by Inducing Inflammation and Suppressing Host Immunity[J]. Transl Oncol2019, 12(6): 846-851.
[22]
Teles FRFAlawi FCastilho RM,et al. Association or Causation?Exploring the Oral Microbiome and Cancer Links[J]. J Dent Res2020, 99(13): 1411-1424.
[23]
Geng FZhang YLu Z,et al. Fusobacterium nucleatum Caused DNA Damage and Promoted Cell Proliferation by the Ku70/p53 Pathway in Oral Cancer Cells[J]. DNA Cell Biol2020, 39(1): 144-151.
[24]
Schwabe RFJobin C. The microbiome and cancer[J]. Nat Rev Cancer2013, 13(11): 800-812.
[25]
Wu JWang YJiang Z. Immune induction identified by TMT proteomics analysis in Fusobacterium nucleatum autoinducer-2 treated macrophages[J]. Expert Rev Proteomics2020, 17(2): 175-185.
[26]
Udayasuryan BAhmad RNNguyen TTD,et al. Fusobacterium nucleatum induces proliferation and migration in pancreatic cancer cells through host autocrine and paracrine signaling[J]. Sci Signal2022, 15(756): eabn4948.
[27]
Alkharaan HLu LGabarrini G,et al. Circulating and Salivary Antibodies to Fusobacterium nucleatum Are Associated With Cystic Pancreatic Neoplasm Malignancy[J]. Front Immunol2020, 11:2003.
[28]
Riccardi CNapolitano EPlatella C,et al. Anti-VEGF DNA-based aptamers in cancer therapeutics and diagnostics[J]. Med Res Rev2021, 41(1): 464-506.
[29]
Propper DJBalkwill FR. Harnessing cytokines and chemokines for cancer therapy[J]. Nat Rev Clin Oncol2022, 19(4): 237-253.
[30]
Xiao YCong MLi J,et al. Cathepsin C promotes breast cancer lung metastasis by modulating neutrophil infiltration and neutrophil extracellular trap formation[J]. Cancer Cell2021, 39(3): 423-437.e7.
[31]
Pretre VPapadopoulos DRegard J,et al. Interleukin-1(IL-1)and the inflammasome in cancer[J]. Cytokine2022, 153:155850.
[32]
Demling ADemling CSchwestka-polly R,et al. Influence of lingual orthodontic therapy on microbial parameters and periodontal status in adults[J]. Eur J Orthod2009, 31(6): 638-642.
[33]
郭杨,张玉杰,肖水清. 具核梭杆菌生物学特性及检测手段的研究进展[J]. 国际口腔医学杂志2012, 39(06): 770-774.
[34]
Kim HSSong SKYoo SY,et al. Development of strain-specific PCR primers based on a DNA probe Fu12 for the identification of fusobacterium nucleatum subsp. nucleatum ATCC 25586T[J]. J Microbiol2005, 43(4): 331-336.
[35]
Suchett-kaye GMorrier JJBarsotti O. Clinical usefulness of microbiological diagnostic tools in the management of periodontal disease[J]. Res Microbiol2001, 152(7): 631-639.
[36]
Boutaga KVan Winkelhoff AJVandenbroucke-grauls CM,et al. The additional value of real-time PCR in the quantitative detection of periodontal pathogens[J]. J Clin Periodontol2006, 33(6): 427-433.
[37]
赵建国,廖泉,赵玉沛. 胰腺癌分子标志物研究进展[J/CD]. 中华普外科手术学杂志(电子版)2013, 7(03): 224-226.
[1] 马中正, 杨云川, 马翔, 周迟, 丁丁, 霍俊一, 徐楠, 崔培元, 周磊. 胰腺癌双硫死亡相关的lncRNA预后模型的构建及免疫反应研究[J/OL]. 中华普通外科学文献(电子版), 2024, 18(05): 368-376.
[2] 罗文斌, 韩玮. 胰腺癌患者首次化疗后中重度骨髓抑制的相关危险因素分析及预测模型构建[J/OL]. 中华普通外科学文献(电子版), 2024, 18(05): 357-362.
[3] 苗毅. 合并动脉侵犯胰腺癌的形态学观察与可切除性评估[J/OL]. 中华普通外科学文献(电子版), 2024, 18(03): 185-185.
[4] 付成旺, 杨大刚, 王榕, 李福堂. 营养与炎症指标在可切除胰腺癌中的研究进展[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 704-708.
[5] 史成宇, 季晓琳, 田莉莹, 张来香. 腹腔镜胰十二指肠切除术中第14c/d组淋巴结清扫在胰头癌中的临床效果研究[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(04): 430-433.
[6] 魏孔源, 仵正, 王铮, 黎韡. 机器人胰腺中段切除后远端胰腺消化道不同重建方式初探[J/OL]. 中华腔镜外科杂志(电子版), 2024, 17(05): 295-300.
[7] 郭诗翔, 谭明达, 王槐志. 胰头癌淋巴结清扫再思考[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(05): 625-628.
[8] 张昊, 潘卫东. 胰腺癌新辅助化疗后可切除性评估现状及进展[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(05): 629-633.
[9] 周倜, 吴嘉, 韩方, 徐林伟, 张宇华. 新辅助治疗时代胰腺癌淋巴结清扫研究进展[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(05): 634-639.
[10] 王军华, 王锐炫. 胰腺癌新辅助化疗现状和治疗策略[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(05): 640-643.
[11] 魏妙艳, 徐近. 合并远处转移胰腺癌系统性治疗的梳理和展望[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(05): 644-650.
[12] 罗柳平, 吴萌萌, 陈欣磊, 林科灿. 胰腺全系膜切除在胰头癌根治术中的应用价值[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(05): 651-656.
[13] 张瑜, 姜梦妮. 基于DWI信号值构建局部进展期胰腺癌放化疗生存获益预测模型[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(05): 657-664.
[14] 杨秀君, 崔梦莹, 刘水, 盛基尧, 张丹. 基于SEER数据库胰头部胰腺神经内分泌癌患者预后列线图构建与验证[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(04): 520-525.
[15] 危用洋, 黄俊甫, 辛万鹏, 易思清, 涂书举, 方康, 李勇, 肖卫东. 三种术式治疗胰腺颈体部良性或低度恶性肿瘤的临床疗效分析[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(04): 515-519.
阅读次数
全文


摘要


AI


AI小编
你好!我是《中华医学电子期刊资源库》AI小编,有什么可以帮您的吗?